You’ve all heard about the gay content shows being cancelled or censored all over Brasil. Maybe you heard of the Sexualities show at MASP a couple years back as well. MASP is a big institution. It gets big-named curators. And a lot of attention.
Just now there is a theatre piece on HIV being censored in São Paulo.
I came up with the Queer City (or Cidade Queer) a project within Lanchonete.org as a response to contracting HIV in São Paulo a few years before. I am happy with how Cidade Queer performed as a project. During its span in 2015/16, research would have been done for the forthcoming Sexualities show at MASP. In 2017 we were still making programming with a strong Canadian partner. I had a part-time job with that organization, resulting from a ten-year grant-receiving relationship during which I also served as creative director to some major foundation programs. I deployed a 20-year global cultural network to each program I took on for the Canadian organization. I forgot my HIV meds on one of my many international trips in 2017 working for the foundation. I asked for a ‘cost of living allowance’ /COLA-related increase on my next contract near the end of 2017. It was related to the cost of international travel insurance that would cover medication replacement. I was pouting about this once over dinner with a friend, an HIV+ medical doctor. He responded that he’d lost his medical post the week after he presented ideas on a panel at the Queer City finale, an international ball and awareness-raising day on a range of ‘queer’ issues. In that I understood that I was not alone. I recently got to go to Egypt and on way back met an exiled Egyptian activist living with his partner in Paris. He raised his voice about the government stalling his HIV meds, and he was beaten up one night in his apartment. Other serious danger signals happened: threats. They left to Paris and began advocacy work on the situation in Egypt and Middle East. I spoke to a Mexican artist who moved to Berlin after falling blind due to lack of access to HIV meds. These stories pile up as I survey my peers on their regions and conditions in preparation for Luv ’til it Hurts.
Read More